Antigen quantity is responsible for the discrepancy between phenotype and single antigen beads for the detection of HLA-DQ antibody: potential clinical implications.
N Remi Shih,Thoa Nong,Robert A Bray,Cathi Murphey,Ina Skaljic,Howard M Gebel,Mayra Lopez-Cepero,Peter W Nickerson,Jar-How Lee
{"title":"Antigen quantity is responsible for the discrepancy between phenotype and single antigen beads for the detection of HLA-DQ antibody: potential clinical implications.","authors":"N Remi Shih,Thoa Nong,Robert A Bray,Cathi Murphey,Ina Skaljic,Howard M Gebel,Mayra Lopez-Cepero,Peter W Nickerson,Jar-How Lee","doi":"10.1016/j.ajt.2025.04.007","DOIUrl":null,"url":null,"abstract":"De novo donor-specific HLA-DQ antibodies detected by single antigen beads (SAB) are significantly associated with chronic antibody-mediated rejection and lower overall graft survival. However, some DQ antibodies identified by SAB cannot be confirmed by phenotype antigen-bearing Class II bead assays, raising concerns about the validity of SAB data. The inability to detect these antibodies on phenotype antigen beads could be due to a lower quantity of DQ antigens present on the surface of the beads compared to DR antigens. In this study, we demonstrate that DQ-enriched phenotype antigens exhibit the same reactivity with DQ antibodies detected by SAB, confirming the hypothesis that it is antigen quantity and, not structural differences, that account for discrepancies in HLA DQ antibody detection between phenotype antigen beads and SABs. In addition, we show that the expression of individual DQ antigens in heterozygous cells can vary significantly, further confounding correlation studies. Therefore, the common clinical practice of using the phenotype antigen beads as a screening assay, reflexing to SAB testing only when positive, may inadvertently fail to detect DQ-specific antibodies. Such errors could impact organ acceptance practices, immunosuppression treatment decisions and/or the need for additional diagnostic testing to rule out antibody-mediated rejection.","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"5 1","pages":""},"PeriodicalIF":8.9000,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajt.2025.04.007","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
De novo donor-specific HLA-DQ antibodies detected by single antigen beads (SAB) are significantly associated with chronic antibody-mediated rejection and lower overall graft survival. However, some DQ antibodies identified by SAB cannot be confirmed by phenotype antigen-bearing Class II bead assays, raising concerns about the validity of SAB data. The inability to detect these antibodies on phenotype antigen beads could be due to a lower quantity of DQ antigens present on the surface of the beads compared to DR antigens. In this study, we demonstrate that DQ-enriched phenotype antigens exhibit the same reactivity with DQ antibodies detected by SAB, confirming the hypothesis that it is antigen quantity and, not structural differences, that account for discrepancies in HLA DQ antibody detection between phenotype antigen beads and SABs. In addition, we show that the expression of individual DQ antigens in heterozygous cells can vary significantly, further confounding correlation studies. Therefore, the common clinical practice of using the phenotype antigen beads as a screening assay, reflexing to SAB testing only when positive, may inadvertently fail to detect DQ-specific antibodies. Such errors could impact organ acceptance practices, immunosuppression treatment decisions and/or the need for additional diagnostic testing to rule out antibody-mediated rejection.
期刊介绍:
The American Journal of Transplantation is a leading journal in the field of transplantation. It serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science. Published monthly, it provides an essential resource for researchers and clinicians worldwide.
The journal publishes original articles, case reports, invited reviews, letters to the editor, critical reviews, news features, consensus documents, and guidelines over 12 issues a year. It covers all major subject areas in transplantation, including thoracic (heart, lung), abdominal (kidney, liver, pancreas, islets), tissue and stem cell transplantation, organ and tissue donation and preservation, tissue injury, repair, inflammation, and aging, histocompatibility, drugs and pharmacology, graft survival, and prevention of graft dysfunction and failure. It also explores ethical and social issues in the field.